Navigation Links
Quorum Review IRB and ConsentSolutions Form Strategic Alliance
Date:9/5/2013

ofollow">institutional review board fully accredited by the Association for the Accreditation of Human Research Protection Programs (AAHRPP), and has been providing IRB review of drug and device trials since 1992. Quorum oversees research in accordance with U.S. and Canadian human subject research protection regulations and guidelines set forth by the International Committee on Harmonisation (ICH), and principles of the Belmont Report.

Quorum’s best-in-class IRB services include 14 Board meetings each week plus expedited review, 24-hour site review turnaround, 36-hour amendment review turnaround, a secure web portal, and Smart Forms for online submissions. Quorum’s IRB service offerings include full study review in the US and Canada, a specialized Phase I team, and unique processes for post-approval and registry studies.

For more information about Quorum Review, visit http://www.quorumreview.com.

About Consent Solutions

Consent Solutions has been spearheading the development and adoption of electronic consent in the clinical space since 2003. The result of extensive and ongoing research with patients, sponsors, regulatory bodies, CROs and IRBs, the Consent Solutions platform, SecureConsent, takes a patient-centered approach that is supported by video and electronic multimedia to facilitate and enhance patient comprehension. Backed by tightly controlled administrative procedures and controls, granular tracking, sophisticated version control and multi-lingual support, the SecureConsent ecosystem tackles many of the problems of paper-based consenting.

For more information about Consent Solutions, visit http://www.consentsolutions.com.

'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Quorum Review IRB Board Chair Appointed to SACHRP
2. At RSNA, DR Systems Will Exhibit RIS, Reporting, Peer Review Systems
3. Nucleic Acids Research Journal Publishes Sapphire Energy Peer-Reviewed Research Paper on a Chloroplast Genome From Green Algae
4. Unigenes 2011 Year in Review - Key Elements in Place to Address Debt in 2012
5. FDAs Oncologic Drugs Advisory Committee to Review Resubmitted Pixantrone New Drug Application on February 9, 2012
6. Nonprofit Consortium Publishes Review of Skullcap Adulteration
7. Peer-reviewed Article Reports ProImmune's Immune Formulation 200® Activates the Immune-Support Gene Nrf2.
8. Vitamin D Deficiency Disorders Global Clinical Trials Review, H2, 2012
9. BioDelivery Sciences Provides Business Review and Update in Conjunction with Filing of its Second Quarter 2012 Financials
10. Inflammatory Bowel Disease Global Clinical Trials Review, H2, 2012
11. Alzheimers Therapeutics Reviewed by NeuroPerspective
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... Aug. 28, 2015 /PRNewswire/ - RepliCel Life Sciences ... medicine company focused on the development of autologous ... quarter ended June 30, 2015, corporate highlights, and ... report are available at www.sedar.com ,  ... "RepliCel expects to launch its RCS-01 ...
(Date:8/28/2015)... ... August 28, 2015 , ... Since the initial launch of FireflySci Inc. (FFS) in early ... excellent customer service. Images such as the Fonz in a lab coat and Large ... to the humdrum spectroscopy field. , FireflySci is proud to be the only ...
(Date:8/27/2015)... ... August 27, 2015 , ... Capital Edge Consulting , ... problems, is pleased to announce their ranking as one of the top 5000 companies ... fastest-growing private companies across the nation. , “It is truly an honor to be ...
(Date:8/27/2015)... - Portage Biotech Inc. ("Portage") (OTC Market: PTGEF, ... Company Limited (Biohaven), announced today that dosing has ... a glutamate modulating agent. Biohaven filed an investigational ... clearance from the U.S. Food and Drug Administration ... 54% equity interest in Biohaven, a private company. ...
Breaking Biology Technology:RepliCel Reports Second Quarter 2015 Financial Results 2RepliCel Reports Second Quarter 2015 Financial Results 3RepliCel Reports Second Quarter 2015 Financial Results 4RepliCel Reports Second Quarter 2015 Financial Results 5Cuvette Manufacturer FireflySci Launches Back to School Deals with Complimentary Shipping On All Orders 2Capital Edge Consulting Makes Inc. 5000 List of America’s Fastest-Growing Private Companies 2Capital Edge Consulting Makes Inc. 5000 List of America’s Fastest-Growing Private Companies 3Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 2Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 3Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 4
... will provide human safety and, pharmacodynamic ... to announce that its novel Innate Defense Regulator (IDR) ... time on April 27, 2009. The healthy volunteers were ... being performed for Inimex in Montreal with the approval ...
... confirms durable pain palliation as an acceptable primary endpoint, ... of market approval,BOTHELL, WA, April 28 /PRNewswire-FirstCall/ - OncoGenex ... that the company has reached an agreement with the ... of a second Phase 3 registration trial of OGX-011, ...
... SciLIMS Samples and Storage Management Product Line , ... ... , the premier provider of laboratory supplies and instrumentation to academic, ... new set of storage and sample management solutions. E&K is ...
Cached Biology Technology:Inimex Pharmaceuticals begins First Clinical Study of an Innate Defense Regulator 2OncoGenex Receives Confirmation from FDA on the Design of a Second Phase 3 Trial Evaluating OGX-011 for the Treatment of Advanced Prostate Cancer 2OncoGenex Receives Confirmation from FDA on the Design of a Second Phase 3 Trial Evaluating OGX-011 for the Treatment of Advanced Prostate Cancer 3OncoGenex Receives Confirmation from FDA on the Design of a Second Phase 3 Trial Evaluating OGX-011 for the Treatment of Advanced Prostate Cancer 4OncoGenex Receives Confirmation from FDA on the Design of a Second Phase 3 Trial Evaluating OGX-011 for the Treatment of Advanced Prostate Cancer 5OncoGenex Receives Confirmation from FDA on the Design of a Second Phase 3 Trial Evaluating OGX-011 for the Treatment of Advanced Prostate Cancer 6E&K Scientific Announces Partnership with Sciformatix 2
(Date:8/18/2015)... , Aug. 17, 2015 Research and ... of the "Global Biometric Authentication & Identification ... Estimation & Forecast, 2015-2020" report to their ... and identification systems market is expected to grow ... to 2020 and generate over $25 billion (approximately) ...
(Date:8/12/2015)... Aug. 12, 2015  Synaptics Inc. (NASDAQ: ... solutions, today announced that four of its fingerprint ... have officially been named FIDO Certified™ by the ... the certification, Synaptics, Natural ID™ fingerprint solutions are ... Framework (UAF) standard and are interoperable among other ...
(Date:8/6/2015)... and TELTOW, Germany , August ... Siggraph Conference, SensoMotoric Instruments (SMI) shows the ... , based on Epson,s Moverio BT-200 see-through ... platform. With this new solution, unprecedented quality and efficiency ... interaction with context-sensitive displays. For the first time, professionals ...
Breaking Biology News(10 mins):Global Biometric Authentication & Identification Market 2015: Focus On Modality, Motility & Application - Estimation & Forecasts to 2020 for the $25 Billion Industry 2Synaptics Announces FIDO Certification of Natural ID Fingerprint Solutions 2Synaptics Announces FIDO Certification of Natural ID Fingerprint Solutions 3SMI Shows First Eye Tracking Upgrade for Augmented Reality Glasses 2SMI Shows First Eye Tracking Upgrade for Augmented Reality Glasses 3
... comparing breastfed and formula fed infants across time showed ... than the potential risks associated with infant exposure to ... breastmilk, according to a report published in the December ... , a peer-reviewed journal published by Mary Ann Liebert, ...
... Clemson University professor of physics and astronomy Apparao Rao ... Society. Fellows are elected by their peers for outstanding ... than one half of 1 percent of the membership. ... carbon nanotubes and for elucidating the properties of carbon ...
... Unparalleled warming over the last few decades has triggered ... Western European lakes, say researchers at Queen,s University and ... reports that striking changes are now occurring in many ... rapidly warming Arctic, although typically many decades later. The ...
Cached Biology News:Benefits of breastfeeding outweigh risk of infant exposure to environmental chemicals in breastmilk 2Study links ecosystem changes in temperate lakes to climate warming 2
... peptidomimetics built on the flexible and ... These microarrays are available as part ... Service. Custom Probe Content ... specified. Thousands of customer specified peptide ...
... OPA1-01009, OPEP-01009 is a 16 amino acid (amino acids 3-18) ... (DFF). The sequence of this peptide is (amino to ... S - V - K - L - R - ... R - K(18). This peptide may be used ...
... standard microarray image analysis software because of ... tools, visualizations, automation capabilities, performance and ease ... every GenePix scanner, and it also imports ... types of arrays. A wide range of ...
... Applications Package Superior Protein Detection and ... ProXPRESS 2D Proteomic Imaging System is a ... and general life science research applications. ProXPRESS ... of all dyes in the UV and ...
Biology Products: